Assessment of EyeArt Performance With Retinal Cameras

NCT04984200 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 246

Last updated 2022-11-09

No results posted yet for this study

Summary

The study evaluates the performance of the EyeArt system for detecting diabetic retinopathy from images captured using retinal cameras and operators.

Conditions

Interventions

PROCEDURE

Retinal imaging

Subjects will undergo retinal imaging before and/or after administration of mydriatic agent

DRUG

Mydriatic Agent

Subjects will be administered mydriatic medication to dilate their pupils.

Sponsors & Collaborators

  • Eyenuk, Inc.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-13
Primary Completion
2022-08-19
Completion
2022-08-19
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04984200 on ClinicalTrials.gov